Humboldt Foundation cooperates with Bayer Foundation
Three million EUR for new Humboldt-Bayer Research Fellowships
The Alexander von Humboldt Foundation and the Bayer Science & Education Foundation will soon be awarding joint research fellowships. Until 2018, the Bayer Foundation will be making around three million EUR available to fund approximately ten Humboldt-Bayer Research Fellowships annually. The fellows will be selected from the fields of the life sciences, chemistry and pharmacy together with the applicants for regular Humboldt Research Fellowships for postdoctoral researchers.
In addition to the standard sponsorship provided by the Humboldt Foundation, the fellows will receive additional support from Bayer. The company and its foundation will for example facilitate contacts to people within the corporation, invite fellows to events or foundation alumni meetings, offer advice on career issues and job seeking, provide mentors and arrange factory tours.
For the Humboldt Foundation, cooperating with companies such as Bayer is a valuable instrument enabling it to offer a greater number of fellowships while increasing permeability between industry and research.
The Alexander von Humboldt Foundation has singled out six international junior researchers between 29 and 44 years of age for one of Germany’s most valuable research awards: the winners will each be granted up to €1.65 million. With the Sofja Kovalevskaja Award, young researchers receive ri ... more
The Alexander von Humboldt Foundation has chosen six international researchers to receive one of Germany’s most valuable research awards: the winners will each be granted up to €1.65 million. The 2015 Sofja Kovalevskaja Awards furnish promising researchers with risk capital for innovative p ... more
The universities in the major conurbations Berlin and Munich are in particular demand among foreign researchers according to the Humboldt Rankings released today. The ranking list shows how many researchers have come to Germany on a fellowship from the Humboldt Foundation in the last five y ... more
In 2017, Bayer’s operational business was at the prior-year level. The company made good progress strategically. “We took major steps toward the proposed acquisition of Monsanto,” Management Board Chairman Werner Baumann said on Wednesday at the Financial News Conference in Leverkusen. Phar ... more
The third quarter of 2017 marked a period of further strategic and operational progress for the Bayer Group. “Last quarter we took some important strategic steps,” said Werner Baumann, Chairman of the Board of Management, when he presented the interim report for the third quarter on Thursda ... more
The Bayer Group got off to a very successful start to 2017 and generated strong sales and earnings growth in the first quarter. “At Pharmaceuticals, we once again benefited from the very good performance of our key growth products,” CEO Werner Baumann said when he presented the interim repo ... more
Bayer Technology Services stands for technological competence throughout the service life of processes or units. We support our customers from the development of innovative products and processes to engineering and construction of units, to operating control and optimization – with courage, ... more
Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. In North America, Bayer had 2006 net sales of 7.8 billion euros and employed 17,200 at year end. Bayer’s three s ... more
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earni ... more